Clinical trial

Amlodipine/Atorvastatin (Caduet®) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

NCT01107743

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2010-06-01

PhaseN/A

Study timeline

Study start (unknown)2010-06-01Date precision: month

Registry last updated2021-01-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypertensionunresolved

Angina Pectorisunresolved

Hypercholesterolemiaunresolved

Familial Hypercholesterolemiaunresolved

Interventions

Amlodipine/AtorvastatinDRUG

Sponsors & collaborators

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01107743 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.